• Purchase price of approximately $8.2 million
  • The acquisition represents a continued expansion of PharmaCorp’s footprint in Ontario

SASKATOON, Saskatchewan, May 25, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy acquisition and ownership platform for pharmacist-led community pharmacy ownership, today announced that it has entered into a definitive share purchase agreement, dated May 22, 2026 (the “Agreement”) to acquire from an arm’s length vendor group a 100% interest in a PharmaChoice Canada bannered pharmacy located in Morrisburg, Ontario (the “Acquisition”). The Acquisition continues the expansion of the Corporation’s geographical footprint and operating scale. Further to PharmaCorp’s acquisition pipeline update announced in its press release dated April 30, 2026, in which the Corporation disclosed having executed non-binding LOIs, dated February 23, 2026, February 27, 2026, March 3, 2026 and March 23, 2026, respectively, in respect of four additional pharmacy acquisitions (the “LOIs”), this Acquisition represents the first conversion of those LOIs into a definitive share purchase agreement.

Globenewswire